Recombinant t-PA in myocardial ischemia after switch operation

Area of Science:

• Cardiovascular Surgery
• Pediatric Cardiology
• Interventional Cardiology

Background:

• Transposition of the great arteries (TGA) is a congenital heart defect requiring surgical correction.
• The arterial switch operation (ASO) is a common procedure for TGA, but can lead to coronary artery obstruction.
• Myocardial infarction (MI) is a serious complication following ASO due to coronary obstruction.

Observation:

• A 3-month-old infant developed myocardial infarction 11 weeks post-ASO.
• The infant presented with symptoms indicative of coronary artery obstruction.
• Previous treatments for post-ASO coronary obstruction include surgical revascularization and angioplasty.

Findings:

• Recombinant tissue-type plasminogen activator (Alteplase) infusion was administered to the infant.
• Myocardial reperfusion was successfully established following Alteplase infusion.
• This represents a novel approach to managing MI in the context of ASO complications.

Implications:

• Alteplase may be a viable therapeutic option for myocardial infarction secondary to coronary artery obstruction after ASO.
• This case highlights the potential for pharmacologic intervention in managing ASO-related complications.
• Further research is warranted to evaluate the safety and efficacy of Alteplase in this specific clinical scenario.